Clinical Trial Update: The Impact of Pectin Supplementation on Systematic Inflammation Pathway, Gut Microbiome, and Metabolic Health in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) [NA]

View source ↗

Summary

ClinicalTrials.gov listing for a recruiting study evaluating the effects of pectin supplementation on systemic inflammation, the gut microbiome, and metabolic h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Dysfunction-associated Steatotic Liver Disease
• Nonalcoholic Fatty Liver Disease

Drugs mentioned

• Pectin supplement (pectin)

Snippet

Sponsor: University of Nottingham | Conditions: Nonalcoholic Fatty Liver Disease, Nonalcoholic Fatty Liver Disease (NAFLD) | NA | Status: RECRUITING